Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
biotech venture capital
Biotech
US may be ending grants for biotechs with foreign investors
HHS is allegedly canceling clinical trial funding for biotechs with ties to certain foreign investors, Fierce Biotech has learned.
Gabrielle Masson
Jun 18, 2025 11:50am
Fierce Biotech Fundraising Tracker: Antares, Mosanna & more
Jun 18, 2025 9:00am
Neuro-focused Draig hatches with red-hot $140M series A
Jun 18, 2025 12:01am
Scorpion spinout Antares raises $177M for preclinical portfolio
Jun 10, 2025 10:07am
Big Pharma-backed GlycoEra raises $130M for protein degraders
May 27, 2025 7:00am
VC firm to build biotech incubator in NJ life sciences complex
May 15, 2025 9:00am
